Dramatically, a combination of ACE inhibitor and sEH inhibitor did not elicit a significant elevation in survival rate (53%), while ACE inhibitor alone showed a significant effect on the course of CHF with a survival rate of 84% (Kala et al., 2018). This evidence concerns the gene EPHX2 and congestive heart failure.